Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
컨센서스 평점1
Buy
최고 목표 주가1
$125.00
최저 목표 주가1
$82.00
컨센서스 가격 목표1
$102.50
Stride Inc의 컨센서스 목표 주가는 $102.5이며, 6명의 애널리스트 평가를 기반으로 합니다. 최고 목표가는 4월 16, 2026에 Barrington Research가 발표한 $125이고, 최저 목표가는 11월 7, 2025에 BMO Capital가 발표한 $82입니다. 가장 최근의 애널리스트 평가 3건은 Barrington Research, Canaccord Genuity 및 Barrington Research가 4월 16, 2026, 1월 28, 2026 및 1월 28, 2026에 발표했습니다. Barrington Research, Canaccord Genuity 및 Barrington Research 사이의 평균 목표 주가는 $125이며, 이 최신 평가들로부터 Stride Inc에 대한 48.17% upside가 시사됩니다.
1애널리스트 평가로부터 계산됨
Stride (NYSE:LRN)의 최신 목표 주가는 4월 16, 2026에 Barrington Research에 의해 보고되었습니다. 이 애널리스트 기관은 $125.00에 대한 가격 목표를 설정했으며, 12개월 이내에 LRN이(가) rise될 것으로 예상합니다 (가능한 48.17% upside). 지난 1년간 12개의 애널리스트 기관이 평가를 보고했습니다.
Stride (NYSE:LRN)에 대한 최신 애널리스트 평가는 Barrington Research에 의해 제공되었으며, Stride은(는) outperform 평가를 유지했다합니다.
Stride에 대한 마지막 업그레이드가 없습니다.
Stride Inc에 대한 마지막 다운그레이드는 10월 29, 2025에 발생했습니다. 이 때 BMO Capital가 Stride Inc에 대해 가격 목표를 $164에서 $108로 변경했습니다.
애널리스트들은 주식 평가를 내리기 위해 철저한 연구를 진행합니다. 이 연구에는 공개된 재무 보고서를 검토하고, Stride의 경영진 및 고객과 대화하며, 실적 회의 통화를 듣는 것이 포함됩니다. 대부분의 애널리스트들은 이를 매 분기마다 수행하므로, 한 해에는 회사당 애널리스트 당 4번의 평가를 받을 수 있습니다. Stride에 대한 마지막 평가는 4월 16, 2026에 제출되었으므로, 다음 평가가 4월 16, 2027쯤에 제공될 것으로 예상됩니다.
평가는 주관적이며 변할 수 있지만, 최신 Stride (LRN) 평가는 유지했다로, 가격 목표는 $125.00에서 $125.00으로 조정되었습니다. 현재 Stride (LRN)의 가격은 $84.36로, 이는 애널리스트의 예측 범위에서 out of입니다.
검색 애널리스트 평가 및 가격 목표 모든 주식에 대한
데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API
시장 데이터 제공 Benzinga API
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Buy Now | Get Alert | ||||||
|---|---|---|---|---|---|---|---|
| 04/16/2026 | Buy Now | 48.17% | Barrington Research | $125 → $125 | Maintains | Outperform | Get Alert |
| 01/28/2026 | Buy Now | 48.17% | Canaccord Genuity | $125 → $125 | Maintains | Buy | Get Alert |
| 01/28/2026 | Buy Now | 48.17% | Barrington Research | $125 → $125 | Maintains | Outperform | Get Alert |
| 01/21/2026 | Buy Now | 48.17% | Barrington Research | $125 → $125 | Maintains | Outperform | Get Alert |
| 12/17/2025 | Buy Now | 12.61% | Morgan Stanley | $130 → $95 | Maintains | Equal-Weight | Get Alert |
| 11/07/2025 | Buy Now | -2.8% | BMO Capital | $108 → $82 | Maintains | Market Perform | Get Alert |
| 10/29/2025 | Buy Now | 48.17% | Canaccord Genuity | $175 → $125 | Maintains | Buy | Get Alert |
| 10/29/2025 | Buy Now | 48.17% | Barrington Research | $185 → $125 | Maintains | Outperform | Get Alert |
| 10/29/2025 | Buy Now | 28.02% | BMO Capital | $164 → $108 | Downgrade | Outperform → Market Perform | Get Alert |
| 10/24/2025 | Buy Now | 107.44% | Canaccord Genuity | $165 → $175 | Maintains | Buy | Get Alert |
| 09/23/2025 | Buy Now | 119.3% | Barrington Research | $185 → $185 | Maintains | Outperform | Get Alert |
| 08/29/2025 | Buy Now | 119.3% | Barrington Research | $170 → $185 | Maintains | Outperform | Get Alert |
| 08/06/2025 | Buy Now | 88.48% | Morgan Stanley | $148 → $159 | Maintains | Equal-Weight | Get Alert |
| 07/24/2025 | Buy Now | 101.52% | Barrington Research | $170 → $170 | Maintains | Outperform | Get Alert |
| 05/01/2025 | Buy Now | 90.85% | BMO Capital | $139 → $161 | Maintains | Outperform | Get Alert |
| 04/30/2025 | Buy Now | 101.52% | Barrington Research | $150 → $170 | Maintains | Outperform | Get Alert |
| 04/28/2025 | Buy Now | 83.74% | Canaccord Genuity | $145 → $155 | Maintains | Buy | Get Alert |
| 04/17/2025 | Buy Now | 77.81% | Barrington Research | $140 → $150 | Maintains | Outperform | Get Alert |
| 04/01/2025 | Buy Now | 64.77% | BMO Capital | $134 → $139 | Maintains | Outperform | Get Alert |
| 03/14/2025 | Buy Now | 65.96% | Barrington Research | $140 → $140 | Maintains | Outperform | Get Alert |
| 03/11/2025 | Buy Now | 71.88% | Canaccord Genuity | $135 → $145 | Maintains | Buy | Get Alert |
| 01/30/2025 | Buy Now | 58.84% | BMO Capital | $122 → $134 | Maintains | Outperform | Get Alert |
| 01/29/2025 | Buy Now | 65.96% | Barrington Research | $130 → $140 | Maintains | Outperform | Get Alert |
| 01/29/2025 | Buy Now | 60.03% | Canaccord Genuity | $130 → $135 | Maintains | Buy | Get Alert |
| 01/27/2025 | Buy Now | 54.1% | Canaccord Genuity | $100 → $130 | Maintains | Buy | Get Alert |
| 01/17/2025 | Buy Now | 54.1% | Barrington Research | $100 → $130 | Maintains | Outperform | Get Alert |
| 12/12/2024 | Buy Now | 29.21% | Morgan Stanley | $94 → $109 | Maintains | Equal-Weight | Get Alert |
| 10/29/2024 | Buy Now | 11.43% | Citigroup | $90 → $94 | Maintains | Neutral | Get Alert |
| 10/24/2024 | Buy Now | 4.31% | BMO Capital | $84 → $88 | Maintains | Outperform | Get Alert |
| 10/23/2024 | Buy Now | 18.54% | Barrington Research | $90 → $100 | Maintains | Outperform | Get Alert |
| 10/23/2024 | Buy Now | 18.54% | Canaccord Genuity | $94 → $100 | Maintains | Buy | Get Alert |
| 10/11/2024 | Buy Now | 6.69% | Barrington Research | $90 → $90 | Maintains | Outperform | Get Alert |
| 09/20/2024 | Buy Now | 6.69% | Barrington Research | $90 → $90 | Maintains | Outperform | Get Alert |
| 08/20/2024 | Buy Now | 6.69% | Citigroup | $77 → $90 | Downgrade | Buy → Neutral | Get Alert |
| 08/08/2024 | Buy Now | 6.69% | Barrington Research | $85 → $90 | Maintains | Outperform | Get Alert |
| 08/08/2024 | Buy Now | -2.8% | BMO Capital | $79 → $82 | Maintains | Outperform | Get Alert |
| 08/08/2024 | Buy Now | 11.43% | Canaccord Genuity | → $94 | Initiates | → Buy | Get Alert |
| 07/31/2024 | Buy Now | 0.76% | Barrington Research | $75 → $85 | Maintains | Outperform | Get Alert |
| 04/25/2024 | Buy Now | -13.47% | BMO Capital | $72 → $73 | Maintains | Outperform | Get Alert |
| 04/24/2024 | Buy Now | -11.1% | Barrington Research | $75 → $75 | Maintains | Outperform | Get Alert |
| 04/17/2024 | Buy Now | -11.1% | Barrington Research | $75 → $75 | Maintains | Outperform | Get Alert |
| 01/29/2024 | Buy Now | -11.1% | Citigroup | $70 → $75 | Maintains | Buy | Get Alert |
| 01/25/2024 | Buy Now | -14.65% | BMO Capital | $71 → $72 | Maintains | Outperform | Get Alert |
| 01/24/2024 | Buy Now | -22.95% | Morgan Stanley | $60 → $65 | Maintains | Equal-Weight | Get Alert |
| 01/24/2024 | Buy Now | -11.1% | Barrington Research | $70 → $75 | Maintains | Outperform | Get Alert |
| 12/04/2023 | Buy Now | -17.02% | Barrington Research | → $70 | Reiterates | Outperform → Outperform | Get Alert |
| 11/16/2023 | Buy Now | -20.58% | BMO Capital | $57 → $67 | Maintains | Outperform | Get Alert |
| 11/16/2023 | Buy Now | -28.88% | Morgan Stanley | $57 → $60 | Maintains | Equal-Weight | Get Alert |
| 10/26/2023 | Buy Now | -32.43% | BMO Capital | $50 → $57 | Maintains | Outperform | Get Alert |
| 10/25/2023 | Buy Now | -28.88% | Barrington Research | $50 → $60 | Maintains | Outperform | Get Alert |
| 10/25/2023 | Buy Now | -32.43% | Morgan Stanley | $52 → $57 | Maintains | Equal-Weight | Get Alert |